Charles River Laboratories International Inc reports results for the quarter ended June 30 - Earnings Summary

Charles River Laboratories International

06/08/2025 14:31

Charles River Laboratories International Inc CRL.N reported quarterly adjusted earnings of $3.12​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $2.80.  The mean expectation of fourteen analysts for the quarter was for earnings of $2.50 per share. Wall Street expected results to range from $2.46  to $2.51 per share.

Revenue rose 0.6% to $1.03 billion from a year ago; analysts expected $985.06 million.

Charles River Laboratories International Inc's reported EPS for the quarter was $1.06​.

The company reported quarterly net income of $52.33 million.

Charles River Laboratories International Inc shares had risen by 10.4% this quarter and lost 9.3% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 2.2% in the last three months.​

In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy," 13 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is  "buy."

Wall Street's median 12-month price target for Charles River Laboratories International Inc is $163.21, about 2.6% below its last closing price of $167.49

This summary was machine generated from LSEG data August 6 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
2.50
3.12
Beat
Mar. 31 2025
2.08
2.34
Beat
Dec. 31 2024
2.53
2.66
Beat
Sep. 30 2024
2.43
2.59
Beat